In partnership with Medtronic Ltd, RYSE Asset Management and Chelsea and Westminster Hospital NHS Foundation Trust and its official charity CW+

Are you a health-tech start-up founder, innovator, researcher, or technologist with innovation to enable system-wide change in real-world cardiovascular disease patient care pathways? Then you could be in with the chance to be part of this first of its kind investor partnership.

The aim: To identify and implement solutions that empower patients to improve their heart health and help prevent future heart attacks or strokes through home-based digital solutions. 

Challenge: Identifying and scaling innovations for non-invasive lipid testing and at-home blood pressure testing using software as a medical device. Innovations at venture from a research paper to fully formed product or an extension / new evolution of an existing product will be considered.

Successful applicants will receive:

  • Unrivalled support from industry-leading partners during the competition process.
  • Opportunity of investment up to £3 million provided by RYSE Asset Management, subject to due diligence at RYSE`s discretion.
  • Access to the Novartis Biome UK eco-system
  • Opportunities to work with our NHS partners to set up and deliver a pilot evaluation of the winning innovation.

Apply today

Deadline 31st August 2022 - For help with entries please contact [email protected]

Status message

Sorry… This form is closed to new submissions.